Browsing: Weight Loss

On Tuesday, Novo Nordisk initiated legal action against Eli Lilly, claiming the company’s promotional efforts for its popular obesity and diabetes medications intentionally deceive patients regarding their greater effectiveness compared to Novo’s competing products. The company objects to national advertisements that reference what it describes as obsolete study data, using those comparisons to pit the…

Plainsboro, NJ and Bagsværd, Denmark, 21 July 2026 – Novo Nordisk Inc. announced today that it has filed a lawsuit against Eli Lilly and Company and Lilly USA, LLC in the United States District Court for the District of New Jersey for multiple violations of federal and state false advertising and unfair competition laws, including under…